Logo image of CYTO

ALTAMIRA THERAPEUTICS LTD (CYTO) Stock Analyst Ratings

USA - NASDAQ:CYTO - BMG0360L1349 - Common Stock

0.3 USD
-0.11 (-25.94%)
Last: 12/19/2024, 10:21:17 PM
0.262 USD
-0.04 (-12.67%)
After Hours: 12/19/2024, 10:21:17 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CYTO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 5.41. This target is 1702% above the current price.
CYTO was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CYTO.
In the previous month the buy percentage consensus was at a similar level.
CYTO was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

CYTO Historical Analyst RatingsCYTO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -35 -32 -29 -26 -23 -20 -17 -14 -11 -8 -5 -2 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 0.305.355.415.415.57 - 1,684.33% 1,702.00% 1,702.00% 1,755.00%

Related screens

CYTO Current Analyst RatingCYTO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

ALTAMIRA THERAPEUTICS LTD / CYTO FAQ

Can you provide the average price target for ALTAMIRA THERAPEUTICS LTD stock?

7 analysts have analysed CYTO and the average price target is 5.41 USD. This implies a price increase of 1702% is expected in the next year compared to the current price of 0.3.


What is the consensus rating for ALTAMIRA THERAPEUTICS LTD (CYTO) stock?

The consensus rating for ALTAMIRA THERAPEUTICS LTD (CYTO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.